Peter Schell Email & Phone Number

Biopharma commercial expertise focusing on PIPELINE STRATEGY and LAUNCH READINESS. Get the commercial expertise you need, when you need it, and without paying for the expensive overhead of larger consulting firms or those who rely on more junior consultants. The client approach is simple: understand the singular client need and then deliver the right-sized, right-budgeted deep expertise including leveraging a powerful network of proven functional veterans where and when needed.1. MARKET KNOWLEDGE: Patient journey flow including customer-driver & experience mapping2. MARKET POTENTIAL: TPP Development, Valuations, Due Diligence, Analytic Modeling & NPV Forecasts3. COMMERCIAL RAMP-UP: Organization Ramp-up & Commercial Investment Strategy4. MARKET PREPARATION: Pre-launch Education including KOL Scientific Exchange & Payer P.I.E.5. LAUNCH PLANS: Creation (or assessment/refinement) of go-to-market strategy & launch plansUnique Frameworks:- Customer Driver Sets (patient/caregiver, provider, payer)- Simplified Patient Flow and Commercial Points-of-Interest- Scientific and Pre-Approval Information Exchange- Return-on-Experience (ROE)

Global, Gb

Senior leader providing commercial & medical strategic expertise and solutions to help clients optimize pipelines, create #1 new product launches, and maximize brand lifecycles, LOE and portfolios. Sales or project involvement in >$2M covering (1) Pipeline Assessments & Optimization (2) Launch Excellence (3) Lifecycle Strategy/LOE.

Wayne, Pa, Us

Senior leader provided commercial strategy expertise for a number of Fortune 500 biopharma clients covering pipeline strategy, launch excellence and LCM innovation needs, including go-to-market strategy and launch roadmaps (multiple pipeline blockbusters), post-launch course correction/revitalized growth strategy, lifecycle strategy (leading CVM blockbuster); alliance partnership optimization.

Biopharma commercial strategic planning solutions for emerging and small biotech and pharma companies, including market landscaping, go-to-market commercial strategy & NPV forecasts to inform go/no-go decisions, and commercial operations optimization, including alliance partnerships.

San Francisco, California, Us

Head of Commercial & Corporate Strategy, and Executive Team member responsible for creating the commercial infrastructure and launch of 1st product, Liletta. Key accomplishments: Created the commercial organization from the ground-up, overseeing all commercial activites; Transforming Medicines360 from a R&D organization to a revenue-producing cmmercial organization; Led the successful launch of 1st product LILETTA (with alliance partner Allergan, now Abbvie); Led corporate communications increasing corporate profile recall by +100%; Designed/implemented the corporate strategic planning processes and the 5-year strategic plan; Deep-dive assessment of women's health landscape for licensing or acquisition opportunities.

President/Founder of Newaygo PharmaGroup, a biopharma commercial consultancy providing commercial strategy and operations solutions to 25+ clients with a team of 20+ senior executive consultants. Key services: Pipeline Strategy, Go-to-makret planning; Commercial infrastructure planning; Customer Engagement Policy/Process Optimization & Training; Tone from the Middle turn-key program (Sales excellence via middle managers); Newaygo Regional Field Monitoring Team.

New York, New York, Us

Progressive commercial leadership roles including US Brand (INSPRA launch); US Commercial Operations; Global LIPITOR (launch & Major Market leadership); Pfizer Co-chair Commercial Policy Committee.

Pfizer: Brand Team Leader, Market Research LeaderMerck: Business Analyst, Professional Sales Representative